TriSalus Life Sciences, Inc. — Director's Dealing 2025

Aug 15, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TriSalus Life Sciences, Inc. (TLSI)
CIK: 0001826667
Period of Report: 2025-08-14

Reporting Person: Patience David (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-14	Common Stock	A	200000	—	Acquired	200000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-14	Employee Stock Option (right to buy)	$3.88	A	290000	Acquired	2035-08-13	Common Stock (290000)	Direct

Footnotes

F1: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on July 1, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.

F2: One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of July 1, 2026 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.